Skip to main content
SpringerLink
Log in

Growth hormone and renal osteodystrophy: a case report

  • Dialysis
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract.

A 14-year-old male with end-stage renal disease on hemodialysis was treated with recombinant growth hormone for growth retardation. He developed severe renal osteodystrophy, which responded only to the discontinuation of growth hormone.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Michigan State University, College of Human Medicine, Department of Pediatrics/Human Development, B240 Life Sciences, East Lansing, Michigan 48824-1317, USA, , , , , , US

    Donald B. Kaufman

Authors
  1. Donald B. Kaufman
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Received January 24, 1997; received in revised form August 19, 1997; accepted August 22, 1997

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kaufman, D. Growth hormone and renal osteodystrophy: a case report. Pediatr Nephrol 12, 157–159 (1998). https://doi.org/10.1007/s004670050429

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s004670050429

Search

Navigation